Condition: Hemophilia A · Sponsor: Sanofi
This is a national, multicenter, retrospective/prospective, observational study in Taiwan designed to assess effectiveness, safety, and usage of efanesoctocog alfa prophylaxis treatment in hemophilia A participants. The data related to efanesoctocog alfa effectiveness, safety and usage will be recorded prospectively during routine visits for up to 5 years following enrollment initiation and the retrospective data will be collected at least 12 months and up to 24 months prior to efanesoctocog alfa initiation. Joint imaging data will be collected in centers performing Joint U/S and/or MRI (≥6 years old). At least 12 months of retrospective data will also be collected from medical records, as available. Prospectively collected data will be recorded at routine clinical visits during a five-year follow-up period. The end of study is defined as the last participant's last visit. No intervention will be administered, and no study related visits are required.
This description comes directly from the study's public registry record.
Trial Transparency email recommended (Toll free for US & Canada) · 800-633-1610 · Contact-US@sanofi.com
Always discuss trial participation with your own doctor first.
| Investigational Site Number : 1580008 | Changhua, Taiwan | Recruiting |
| Investigational Site Number : 1580009 | Kaohsiung City, Taiwan | Recruiting |
| Investigational Site Number : 1580010 | Kaohsiung City, Taiwan | Recruiting |
| Investigational Site Number : 1580005 | Taichung, Taiwan | Recruiting |
| Investigational Site Number : 1580006 | Taichung, Taiwan | Recruiting |
| Investigational Site Number : 1580007 | Taichung, Taiwan | Recruiting |
| Investigational Site Number : 1580001 | Taipei, Taiwan | Recruiting |
| Investigational Site Number : 1580003 | Taipei, Taiwan | Recruiting |
| Investigational Site Number : 1580002 | Taipei, Taiwan | Recruiting |
| Investigational Site Number : 1580004 | Taoyuan City, Taiwan | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06684314